Compare RYAM & LXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RYAM | LXRX |
|---|---|---|
| Founded | 1926 | 1995 |
| Country | United States | United States |
| Employees | 2325 | N/A |
| Industry | Paper | Biotechnology: Pharmaceutical Preparations |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 661.8M | 703.3M |
| IPO Year | 2014 | 2000 |
| Metric | RYAM | LXRX |
|---|---|---|
| Price | $8.97 | $1.96 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | ★ $14.00 | $4.15 |
| AVG Volume (30 Days) | 700.8K | ★ 1.9M |
| Earning Date | 05-05-2026 | 05-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 77.78 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,466,397,000.00 | $49,803,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $8.22 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 60.24 |
| 52 Week Low | $3.35 | $0.70 |
| 52 Week High | $11.85 | $2.53 |
| Indicator | RYAM | LXRX |
|---|---|---|
| Relative Strength Index (RSI) | 52.89 | 49.71 |
| Support Level | $8.22 | $1.50 |
| Resistance Level | $9.34 | $2.53 |
| Average True Range (ATR) | 0.37 | 0.11 |
| MACD | 0.08 | -0.02 |
| Stochastic Oscillator | 74.67 | 33.33 |
Rayonier Advanced Materials Inc engaged in the production and sale of high-purity cellulose and other cellulose-based materials derived from renewable wood fiber. The company operates through five segments: Cellulose Specialties, which produces purified cellulose used in products such as filters, pharmaceuticals, food additives and electronics; Biomaterials, which produces products including biofuels, lignosulfonates and other bio-based chemicals; Cellulose Commodities, which manufactures absorbent and viscose pulp used in textiles and hygiene products; Paperboard, which produces coated paperboard used for packaging and printing applications; and High-Yield Pulp, which produces pulp used in paperboard, packaging and printing paper products.
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, and LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.